• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    4/19/24 1:25:08 PM ET
    $AGBA
    $AMC
    $AULT
    $BGLC
    Investment Managers
    Finance
    Movies/Entertainment
    Consumer Discretionary
    Get the next $AGBA alert in real time by email

    Shares of Super Micro Computer, Inc. (NASDAQ:SMCI) fell sharply during Friday's session.

    The company announced its third-quarter earnings date and did not provide preliminary estimates as it did with the second quarter.

    Super Micro Computer shares dipped 13.2% to $806.00 on Friday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Next.e.GO N.V. (NASDAQ:EGOX) shares jumped 129% to $0.0817.
    • Redwoods Acquisition Corp. (NASDAQ:RWOD) shares rose 62.5% to $12.03 after falling around 3% on Thursday.
    • Zhongchao Inc. (NASDAQ:ZCMD) gained 50% to $2.16 after gaining over 7% on Thursday.
    • Ault Alliance, Inc. (NYSE:AULT) surged 46% to $0.3544 after the company announced that it received an investment of $44 million to date from Ault & Company under the November 2023 Securities Purchase Agreement.
    • Nova LifeStyle, Inc. (NASDAQ:NVFY) rose 31% to $2.77.
    • AGBA Group Holding Limited (NASDAQ:AGBA) gained 24.3% to $0.0817 on continued upward momentum after the company announced it entered into a definitive merger agreement with Triller.
    • Brenmiller Energy Ltd (NASDAQ:BNRG) surged 21.4% to $2.50.
    • WiSA Technologies, Inc. (NASDAQ:WISA) rose 21.2% to $7.14.
    • Mobile-health Network Solutions (NASDAQ:MNDR) climbed 20.2% to $24.53.
    • Marti Technologies, Inc. (NYSE:MRT) surged 19% to $1.8450.
    • Metropolitan Bank Holding Corp. (NYSE:MCB) gained 19% to $39.40 after the company reported better-than-expected first-quarter financial results.
    • Top Wealth Group Holding Limited (NASDAQ:TWG) gained 19% to $2.21. Top Wealth Group successfully closed IPO, raising $8 million.
    • Next Technology Holding Inc. (NASDAQ:NXTT) jumped 17.2% to $6.13.
    • Trio Petroleum Corp. (NYSE:TPET) gained 16.4% to $0.3817. The company on Wednesday announced it entered into a securities purchase agreement with an institutional investor in the amount of $360,000.
    • SuperCom Ltd. (NASDAQ:SPCB) gained 16.3% to $0.2792. SuperCom shares fell around 33% on Thursday after the company priced a $2.9 million registered direct offering.
    • Chromocell Therapeutics Corporation (NASDAQ:CHRO) rose 15.9% to $1.42.
    • Humacyte, Inc. (NASDAQ:HUMA) rose 12.2% to $4.03.
    • Paramount Global (NASDAQ:PARA) shares gained 9.7% to $12.03 following reports suggesting Sony is in talks with Apollo to join a bid for the company.
    • Tellurian Inc. (NYSE:TELL) rose 7.8% to $0.4172.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) gained 4.8% to $3.0589. Wedbush, on Thursday, slashed its price target on the stock to $4 on Thursday.

    Losers

    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) shares fell 37.1% to $2.09. Sunshine Biopharma’s Nora Pharma received Health Canada approval for Niopeg.
    • iSpecimen Inc. (NASDAQ:ISPC) fell 27.3% to $0.3050 after gaining around 98% on Thursday.
    • BioNexus Gene Lab Corp. (NASDAQ:BGLC) fell 23.4% to $0.65 after jumping around 29% on Thursday. BioNexus Gene Lab agreed to invest RM 1.2 million in Ascension Innovation (AISB) to advance digital health innovation through AI adoption in healthcare.
    • Golden Sun Health Technology Group Limited (NASDAQ:GSUN) dipped 21.4% to $3.85.
    • Connexa Sports Technologies Inc. (NASDAQ:YYAI) fell 20% to $1.67.
    • Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) fell 20% to $0.6401 after surging 65% on Thursday.
    • Bit Origin Ltd (NASDAQ:BTOG) fell 19.1% to $2.41.
    • Virgin Galactic Holdings, Inc. (NASDAQ:SPCE) dipped 17% to $0.8019.
    • SeaStar Medical Holding Corporation (NASDAQ:ICU) fell 16.7% to $0.45. SeaStar Medical recently reported worse-than-expected quarterly financial results.
    • Tevogen Bio Holdings Inc. (NASDAQ:TVGN) fell 15.5% to $1.79.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) fell 14.2% to $2.53 after jumping around 32% on Thursday.    
    • Ocular Therapeutix, Inc. (NASDAQ:OCUL) fell 11% to $5.22. HC Wainwright & Co. analyst Yi Chen reiterated Ocular Therapeutix with a Buy and maintained a $16 price target.
    • Skye Bioscience, Inc. (NASDAQ:SKYE) fell 9.8% to $15.16.
    • Netflix, Inc. (NASDAQ:NFLX) fell 7% to $567.78. Netflix reported upbeat earnings and sales results for its first quarter. The company added 9.33 million paid net new subscribers in the first quarter to bring the company to a total of 269.60 million.
    • O-I Glass, Inc. (NYSE:OI) fell 6.4% to $14.41. B of A Securities analyst George Staphos downgraded O-I Glass from Buy to Neutral and lowered the price target from $21 to $16.
    • Spotify Technology S.A. (NYSE:SPOT) fell 4.4% to $276.45.

    Read More: Netflix To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday

    Get the next $AGBA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGBA
    $AMC
    $AULT
    $BGLC

    CompanyDatePrice TargetRatingAnalyst
    Spotify Technology S.A.
    $SPOT
    2/11/2026$875.00 → $420.00Buy → Hold
    Pivotal Research Group
    Spotify Technology S.A.
    $SPOT
    1/30/2026$650.00Neutral → Buy
    Citigroup
    Spotify Technology S.A.
    $SPOT
    1/27/2026$487.00Neutral
    MoffettNathanson
    Netflix Inc.
    $NFLX
    1/23/2026$150.00 → $120.00Outperform
    Robert W. Baird
    Spotify Technology S.A.
    $SPOT
    1/23/2026$700.00Neutral → Buy
    Goldman
    Netflix Inc.
    $NFLX
    1/21/2026$115.00 → $112.00Buy
    TD Cowen
    Netflix Inc.
    $NFLX
    1/21/2026$121.00 → $95.00Outperform
    Wolfe Research
    Netflix Inc.
    $NFLX
    1/21/2026$145.00 → $120.00Buy
    Rothschild & Co Redburn
    More analyst ratings

    $AGBA
    $AMC
    $AULT
    $BGLC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Baird Jennifer A bought $987 worth of shares (4,200 units at $0.24), increasing direct ownership by 13% to 36,200 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    12/22/25 6:55:38 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Messinger Michael bought $5,098 worth of shares (14,500 units at $0.35), increasing direct ownership by 483% to 17,500 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    12/11/25 6:49:59 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Director Fabiano Anthony J bought $9,978 worth of shares (147 units at $67.87), increasing direct ownership by 1% to 12,680 units (SEC Form 4)

    4 - Metropolitan Bank Holding Corp. (0001476034) (Issuer)

    11/3/25 6:55:05 PM ET
    $MCB
    Major Banks
    Finance

    $AGBA
    $AMC
    $AULT
    $BGLC
    SEC Filings

    View All

    SEC Form 10-K filed by O-I Glass Inc.

    10-K - O-I Glass, Inc. /DE/ (0000812074) (Filer)

    2/12/26 4:31:29 PM ET
    $OI
    Containers/Packaging
    Consumer Discretionary

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    2/12/26 4:30:05 PM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SCHEDULE 13G filed by Metropolitan Bank Holding Corp.

    SCHEDULE 13G - Metropolitan Bank Holding Corp. (0001476034) (Subject)

    2/12/26 9:05:15 AM ET
    $MCB
    Major Banks
    Finance

    $AGBA
    $AMC
    $AULT
    $BGLC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Liaw Yih-Shyan Wally converted options into 9,598 shares and covered exercise/tax liability with 3,684 shares, increasing direct ownership by 7% to 92,312 units (SEC Form 4)

    4 - Super Micro Computer, Inc. (0001375365) (Issuer)

    2/12/26 5:27:54 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    SVP, Worldwide Sales Clegg Don W covered exercise/tax liability with 953 shares and converted options into 2,310 shares, increasing direct ownership by 3% to 48,025 units (SEC Form 4)

    4 - Super Micro Computer, Inc. (0001375365) (Issuer)

    2/12/26 5:17:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    President and CEO Liang Charles converted options into 2,110 shares and covered exercise/tax liability with 1,251 shares (SEC Form 4)

    4 - Super Micro Computer, Inc. (0001375365) (Issuer)

    2/12/26 5:14:17 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    $AGBA
    $AMC
    $AULT
    $BGLC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Spotify downgraded by Pivotal Research Group with a new price target

    Pivotal Research Group downgraded Spotify from Buy to Hold and set a new price target of $420.00 from $875.00 previously

    2/11/26 9:23:52 AM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    Spotify upgraded by Citigroup with a new price target

    Citigroup upgraded Spotify from Neutral to Buy and set a new price target of $650.00

    1/30/26 6:41:31 AM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    MoffettNathanson initiated coverage on Spotify with a new price target

    MoffettNathanson initiated coverage of Spotify with a rating of Neutral and set a new price target of $487.00

    1/27/26 8:49:45 AM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    $AGBA
    $AMC
    $AULT
    $BGLC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TIAN RUIXIANG Unveils unprecedented Asia-Pacific AI Healthcare Revolution: Strategic Partnership & Acquisition of Singapore's Top 3 Medical Leaders to Dominate AI-Driven Diagnostics Across Southeast Asia

    Beijing/Singapore, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tian Ruixiang Holdings Limited ("Tianruixiang" or the "Company") (NASDAQ:TIRX), a global trailblazer in AI-powered insurance innovation, today announced a landmark expansion of its transformative ecosystem, cementing its position as the undisputed leader in AI-driven healthcare across Southeast Asia and the Asia-Pacific. Building on its historic AI initiative with top-tier global insurance firms, TIRX has entered into strategic partnership and acquisition discussions with Singapore's top three medical technology leaders, a move set to redefine the future of insurance-clinic integration and precision diagnostics in the region. The propo

    2/12/26 9:32:41 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SuperCom Secures Louisiana Electronic Monitoring Contract, Expands U.S. Presence to 16th New State

    Marks 17th New Service Provider Partnership Since Mid-2024 and Continues Track Record of Incumbent Displacement TEL AVIV, Israel, Feb. 12, 2026 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, today announced a new electronic monitoring (EM) service provider contract in Louisiana. The agreement marks SuperCom's entry into its 16th new U.S. state and its 17th new service provider partnership since mid-2024, further expanding SuperCom's recurring revenue base and U.S. footprint. The Louisiana-based provider has operated electronic monitoring programs across the state for over a decade, managing supervision se

    2/12/26 9:00:00 AM ET
    $SPCB
    Semiconductors
    Technology

    Bit Origin Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement

    SINGAPORE, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Bit Origin Ltd (NASDAQ:BTOG) ("Bit Origin" or the "Company"), today announced that it has received a notification letter from The Nasdaq Stock Market LLC ("Nasdaq") on February 9, 2026, confirming that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). On February 21, 2025, the Company was notified by Nasdaq that its Class A ordinary shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days. According to the notification letter received on February 9, 2026, Nasdaq staff has determined that for the last 14 consecutive business days, f

    2/11/26 9:00:00 AM ET
    $BTOG
    Finance: Consumer Services
    Finance

    $AGBA
    $AMC
    $AULT
    $BGLC
    Leadership Updates

    Live Leadership Updates

    View All

    Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer

    Accomplished global commercial leader with deep expertise in retina drug launches Primary architect for the industry-defining launch of EYLEA® while at Regeneron Most recently served as Chief Marketing Officer, Global Ophthalmology at Merck BEDFORD, Mass., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that David W. Robinson has agreed to join the Company as Global Chief Commercial Officer. The appointment of Mr. Robinson, a proven commercial leader with a history of launching category-defining therapies, strategically positions Ocular for success

    1/21/26 7:00:00 AM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    LAIKA Partners With Fathom Entertainment for Domestic Distribution and FilmNation Entertainment for International Sales on Wildwood

    Confirms October 23, 2026 U.S. Release Date LAIKA, the studio behind Coraline and ParaNorman, announced today that it has partnered with Fathom Entertainment for U.S. theatrical distribution and FilmNation Entertainment for international sales on its upcoming stop-motion feature film Wildwood. The film will open in theaters nationwide on October 23, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120938376/en/LAIKA Names Fathom Entertainment as US Distributor and FilmNation Entertainment for International Sales for "Wildwood" coming October 23, 2026 The announcement reflects a new phase for LAIKA, as the studio expands

    1/20/26 11:15:00 AM ET
    $AMC
    $CNK
    Movies/Entertainment
    Consumer Discretionary

    AMC Theatres Declares Netflix's Stranger Things Series Finale Theatrical Event a Triumph; More Joint Netflix-AMC Cooperation Envisioned in 2026 and Beyond

    Adam Aron, Chairman and CEO of AMC Entertainment (NYSE:AMC), the world's largest theatrical exhibitor, issued the following statement today: "A few months ago, we announced that in September of 2025, a high-level dialogue between AMC and Netflix led to both companies pledging to explore ways to visibly begin working together. This led quickly to AMC showing, in many of its theatres, a Halloween bring-back of Netflix's immensely popular KPop Demon Hunters. It was quite the success. AMC was responsible for more than 35% of all the attendance for KPop Demon Hunters that holiday weekend. So, the two companies immediately turned their focus to what would come next in their mutual cooperation

    1/2/26 9:09:00 AM ET
    $AMC
    Movies/Entertainment
    Consumer Discretionary

    $AGBA
    $AMC
    $AULT
    $BGLC
    Financials

    Live finance-specific insights

    View All

    O-I Glass Reports Full Year and Fourth Quarter 2025 Results

    PERRYSBURG, Ohio, Feb. 10, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE                                       Significantly Improved 2025 Performance Driven By $300 Million Fit To Win BenefitsAnticipate Stronger 2026 Results and Reaffirming O-I's 2027 Investor Day TargetsIncreasing Cumulative Three-Year Fit To Win Benefit Target To At Least $750 Million O-I Glass, Inc. ("O-I") (NYSE:OI) today reported financial results for the full year and fourth quarter ended December 31, 2025. Full Year 2025 Results  Net Sales$MNet Earnings (Loss) Attributable To the CompanyEarnings Per ShareEarnings (Loss) BeforeIncome Taxes$MCash Provided byOperating Activities$MFY25FY24FY25FY24FY25FY24FY25FY24Re

    2/10/26 4:20:00 PM ET
    $OI
    Containers/Packaging
    Consumer Discretionary

    Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

    SOL-1 Phase 3 superiority trial results remain masked to date SOL-1 data expected to be presented at the 49th Macula Society Annual Meeting Ocular plans to submit NDA for AXPAXLI™ in wet AMD based on SOL-1 52 Week data, pending positive results and planned FDA interactions Completed randomization of 631 subjects in SOL-R Phase 3 non-inferiority trial in December 2025; timing of topline results accelerated and now anticipated in 1Q 2027 HELIOS-3 Phase 3 trial in diabetic retinopathy underway Cash balance of $737.1 million as of December 31, 2025, with expected runway into 2028 BEDFORD, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocula

    2/5/26 7:00:00 AM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Supermicro Announces Second Quarter Fiscal Year 2026 Financial Results

    Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company"), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, today announced unaudited financial results for its second quarter of fiscal year 2026 ended December 31, 2025. Second Quarter Fiscal Year 2026 Highlights Net sales of $12.7 billion versus $5.0 billion in Q1'26 and $5.7 billion in Q2'25 Gross margin of 6.3% versus 9.3% in Q1'26 and 11.8% in Q2'25 Net income of $401 million versus $168 million in Q1'26 and $321 million in Q2'25 Diluted net income per common share of $0.60 versus $0.26 in Q1'26 and $0.51 in Q2'25 Non-GAAP gross margin of 6.4% versus 11.9% in Q2'25 Non-GAAP diluted net

    2/3/26 4:51:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    $AGBA
    $AMC
    $AULT
    $BGLC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Brenmiller Energy Ltd

    SC 13D/A - Brenmiller Energy Ltd. (0001901215) (Subject)

    12/5/24 11:18:20 AM ET
    $BNRG
    Building Products
    Industrials

    Amendment: SEC Form SC 13D/A filed by Humacyte Inc.

    SC 13D/A - Humacyte, Inc. (0001818382) (Subject)

    11/20/24 7:10:08 PM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by O-I Glass Inc.

    SC 13G - O-I Glass, Inc. /DE/ (0000812074) (Subject)

    11/20/24 1:29:08 PM ET
    $OI
    Containers/Packaging
    Consumer Discretionary